MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

Inicio・Lista de Acciones・XBiotech Inc

XBiotech Inc

Cerrado

2.64

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.52

Máximo

2.64

Métricas clave
By Trading Economics
Ingresos	9.1M -1.8M
Margen de beneficios	-1,255.363
Empleados	92
EBITDA	9M -1.3M

Dividendos
By Dow Jones
Próximas Ganancias	11 nov 2025

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-7.9M 82M
Apertura anterior	2.64
Cierre anterior	2.64

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

2.8 / 3.04 Soporte y Resistencia

XBiotech Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 oct 2025, 18:59 UTC

Principales Movimientos del Mercado

Intel Shares Rise on Reported Talks to Add AMD as Customer

1 oct 2025, 23:47 UTC

Charlas de Mercado

Nikkei May Rise After Gains on Wall Street -- Market Talk

1 oct 2025, 23:45 UTC

Charlas de Mercado

Gold Edges Lower on Likely Technical Correction -- Market Talk

1 oct 2025, 23:12 UTC

Adquisiciones, fusiones, absorciones

Avalanche Treasury CEO is Bart Smith

1 oct 2025, 23:11 UTC

Adquisiciones, fusiones, absorciones

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

1 oct 2025, 23:07 UTC

Adquisiciones, fusiones, absorciones

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

1 oct 2025, 23:06 UTC

Adquisiciones, fusiones, absorciones

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

1 oct 2025, 23:04 UTC

Adquisiciones, fusiones, absorciones

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

1 oct 2025, 22:41 UTC

Charlas de Mercado

Flight Centre Set for Calm Year After Turbulent FY 2025 -- Market Talk

1 oct 2025, 22:41 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

1 oct 2025, 22:34 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 oct 2025, 22:34 UTC

Charlas de Mercado

AGL Energy Is Less Risky Than the Market Thinks -- Market Talk

1 oct 2025, 22:25 UTC

Ganancias

Webco Industries 4Q EPS $9.18 >WEBC

1 oct 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

1 oct 2025, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

1 oct 2025, 20:33 UTC

Adquisiciones, fusiones, absorciones

Roche Begins Tender Offer for 89bio Pursuant to Previously Announced Merger Agreement

1 oct 2025, 20:30 UTC

Adquisiciones, fusiones, absorciones

Sherwin-Williams Completes $1.15B Purchase of BASF's Brazilian Architectural Paints Business

1 oct 2025, 20:20 UTC

Adquisiciones, fusiones, absorciones

These Stocks Moved the Most Today: Nike, Netflix, Fermi, Moderna, AES, Lithium Americas, Sunrun, Corteva, and More -- Barrons.com

1 oct 2025, 20:19 UTC

Adquisiciones, fusiones, absorciones

GPP Deal Includes Enel's Interests in Oklahoma, Minnesota and North Dakota Facilities

1 oct 2025, 20:16 UTC

Adquisiciones, fusiones, absorciones

GPP Buys All of Enel's Cash-Equity Interests in Five Operating Wind Facilities and Divests a Portion of Its Interests in Two Wind Facilities

1 oct 2025, 20:16 UTC

Adquisiciones, fusiones, absorciones

Harbert Management's Gulf Pacific Power Expands Operating Wind Portfolio in Transaction With Enel Green Power North America

1 oct 2025, 20:13 UTC

Adquisiciones, fusiones, absorciones

This Lithium Stock Is Soaring Again. How Government Money Is Giving It a Boost. -- Barrons.com

1 oct 2025, 20:04 UTC

Charlas de Mercado

Crude Oil Extends Losing Streak -- Market Talk

1 oct 2025, 19:49 UTC

Charlas de Mercado

Natural Gas Surges on Short-Covering Rally -- Market Talk

1 oct 2025, 19:30 UTC

Charlas de Mercado

Precious Metals Jump After Government Closes -- Market Talk

1 oct 2025, 18:15 UTC

Charlas de Mercado

Canada Tamps Down Talk of Dairy Trade Concessions -- Market Talk

1 oct 2025, 18:09 UTC

Charlas de Mercado

Ganancias

Nike and Adidas Duopoly is Back -- Market Talk

1 oct 2025, 18:08 UTC

Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Nike, Netflix, Fermi, Moderna, AES, Lithium Americas, Sunrun, Corteva, and More -- Barrons.com

1 oct 2025, 17:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 oct 2025, 17:45 UTC

Charlas de Mercado

Canadian House Prices Could Be in For Steady Stretch -- Market Talk

Comparación entre iguales

Cambio de precio

XBiotech Inc previsión

Puntuación técnica

By Trading Central

2.8 / 3.04Soporte y Resistencia

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bearish event.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de XBiotech Inc

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.